2011 Annual Biotech Meeting - American Intellectual Property Law ...

tastelesscowcreekBiotechnology

Oct 4, 2013 (3 years and 10 months ago)

74 views

AIPLA Biotechnology Committee

October 20, 2011

Washington Rooms 5 & 6

Marriott
Wardman

Park

Biotechnology Committee Meeting

Agenda

4:30


4:45


Changing of the Guard: Thanking Karen; Welcoming Carol


AIPLA Strategic Plan; Committee Structure & Leadership


Announcements


4:45


5:30

Practice Considerations for Diagnostics and Bioinformatics

Policy & Patentable Subject Matter Considerations

Judy
Roesler
,
Roesler

Law Offices PLLC


Bioinformatics Practice Considerations

Ling
Zhong
,
RatnerPrestia


Divided Infringement Considerations

Jim Kelley, Eli Lilly and Company

AIPLA Vision & Mission

Vision




AIPLA
will expand its role as an innovator, powerful advocate, and visible global
leader in intellectual property through our commitment to education, outreach,
member service, and advocacy.

Mission




We
serve our members,

fostering their professional and leadership development,
helping nurture and mentor them as they advance within our profession, keeping them
informed in an ever
-
evolving legal environment, and enriching the diversity of the
profession in which we practice, while responding to their personal and professional
needs;


We
serve public policy leaders,
whose mission is to develop, implement and maintain
our intellectual property system, assisting them with objective and unbiased analysis,
and helping establish and maintain fair and effective global laws and policies that
stimulate and reward innovation and creative works in keeping with the public interest;


We
serve the public,

providing education as to the daily value and benefits of a strong
intellectual property system that fosters incentives for creativity & innovation, while
balancing the public’s interest in healthy competition, reasonable costs and basic
fairness; and


We
serve our association and its employees,
providing sound management, financial
stability, stable succession, and a vibrant, respectful and collaborative workplace
environment, delivering opportunities and support for all to lead, create and thrive.


AIPLA Strategic Goals


Advocacy
:
AIPLA will provide crucial leadership and unbiased analysis
leading the way for world
-
class policy and decision
-
making, while
attracting membership, ideas, and resources as a highly sought after
and respected thought leader
.


Public
Education:
AIPLA will educate the public about the daily value of
intellectual property so that its importance is understood and
appreciated
.


Member
Service:
AIPLA will support the professional and intellectual
growth of its members through a flexible organizational framework and
innovative channels of communication, delivering outstanding services,
cost
-
effective programs and mentoring opportunities, thereby ensuring
that AIPLA remains the premier intellectual property association, and
attracts IP professionals from around the world.


Global
Outreach:
AIPLA will expand its influence to the global
community and provide leadership and guidance for the development
of sound global intellectual property standards, laws and
policies.




AIPLA Strategic Plan

Strategic Goal

Staff Lead

Exco

Member

Team

Global Outreach

Todd Dickinson

Alan Kasper

Jonathon Richards
* [Lead]

Sharon Israel

Naomi Voegtli*

Sam Helfgott

Chen Wang

Brian Darville

Advocacy

Vince Garlock

Jeffrey Lewis

Mercedes Meyer

[Lead]

David Hill

Phil Johnson

Betty Morgan

Barbara
Fiacco

Member Services

Meghan
Donohoe

Bill Barber

Phil
Petti

[Lead]

Kevin
Tottis

Kim Van
Voorhis

Mark Whitaker*

Georgann

S.
Grunebach

Public Education

Jim Crowne

Wayne Sobon

Michael Piper

[Lead]

Carl
Oppedahl

Bob
Clarida
*

J. Michael Martinez de
Andino

Biotech Committee, Strategic Plan:
Subcommittees, Programs

Subcommittees
Focused on Member Services


Program
Development
: Lynn
Tyler


Biotech Buzz


Case
Law
Updates


USPTO Relations
:
Suzannah

Sundby


Web
Microsite


Membership Communications


Subcommittee Focused on Advocacy


Global Advocacy

(NEW)


Subcommittee
Focused on Global Outreach


International Issues


Subcommittee Focused on Public
Education


Biotech
Patent
Education

(NEW)
: Karen Canady


Other Subcommittees

Diagnostic and Gene Patenting


Being Considered

Biosimilar

& Competition

Tech Transfer & Licensing

Spring

Favor Global Theme


Mid
-
Winter

Favor Public Education Theme

Announcements

Friday, October 21, 3:30
-

5:30
pm

BIOSIMILAR LEGISLATION


IMPLEMENTATION

Food
and Drug/Special Committee on Legislation (Joint Meeting)

We will host
Denise Esposito from the FDA
who will discuss continuing
progress and issues relevant to the Agency’s implementation of the 2009 US
Biosimilars

legislation and
Rick Lit,
Executive
Director,
Regulatory, Amgen
who will discuss some of the short
-
term and long
-
range regulatory
questions surrounding implementation of the
biosimilars

pathway, including
approval requirements, pharmacovigilance, and interchangeability.


Hoover, Mezzanine
Level


5:30
-

6:30 pm, Today

Biotechnology Committee


Socialize after committee meeting.

TBD